Quantum-Si IncorporatedQSI
QSI
About: Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
Employees: 165
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
656% more call options, than puts
Call options by funds: $121K | Put options by funds: $16K
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
9% more funds holding
Funds holding: 97 [Q2] → 106 (+9) [Q3]
1.57% less ownership
Funds ownership: 44.03% [Q2] → 42.46% (-1.57%) [Q3]
18% less capital invested
Capital invested by funds: $56.2M [Q2] → $45.8M (-$10.3M) [Q3]
30% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 33
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$1
23%
downside
Avg. target
$3.25
150%
upside
High target
$5.50
323%
upside
2 analyst ratings
1 positive
50%
1 neutral
50%
0 negative
0%
HC Wainwright & Co. Swayampakula Ramakanth 30% 1-year accuracy 52 / 173 met price target | 323%upside $5.50 | Buy Maintained | 21 Nov 2024 |
Canaccord Genuity Kyle Mikson 46% 1-year accuracy 12 / 26 met price target | 23%downside $1 | Hold Maintained | 13 Nov 2024 |
Financial journalist opinion
Based on 7 articles about QSI published over the past 30 days
Neutral
Business Wire
1 day ago
Quantum-Si's New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a new paper that was submitted to BioRxiv, demonstrating the capabilities of its proprietary bioinformatics tool called ProteoVue, for detecting and quantifying Single Amino Acid Variants (SAAVs). The paper, titled “Detecting Amino Acid Variants Using Next-Generation Protein Sequencing (NGPS),” highlights the transformative potential of.
Neutral
Business Wire
3 days ago
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
Neutral
Business Wire
1 week ago
Quantum-Si Expands International Distribution Network
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Expands International Distribution Network.
Positive
Zacks Investment Research
1 week ago
Are You Looking for a Top Momentum Pick? Why Quantum-Si Incorporated (QSI) is a Great Choice
Does Quantum-Si Incorporated (QSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Neutral
Business Wire
2 weeks ago
Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™.
Neutral
Business Wire
2 weeks ago
Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening.
Neutral
Business Wire
4 weeks ago
Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024. Quantum-Si's Management team announced Platinum™ Pro, the Company's evolution of Platinum, as well as Proteus™, the Company's new cutting-edge proteomics platform of the future, that is now under development. “We are very excited t.
Positive
Benzinga
1 month ago
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
On Wednesday, Quantum-Si Incorporated QSI stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation NVDA to develop its new proteomics platform, Proteus, and advance Quantum-Si's core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing.
Neutral
Business Wire
1 month ago
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio, providing researchers across all market segments in t.
Neutral
Business Wire
1 month ago
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si's core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing. This collaboration aims to significantly enhance data processing speeds to handle the increased data volume from Proteus. By leverag.
Charts implemented using Lightweight Charts™